Nowakowska, Justyna <br/><br/>
T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.  [electronic resource] 

 -  Cytotherapy  Sep 2015 
 - 1280-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-2566 
<br/><br/><label>Standard No.: </label>10.1016/j.jcyt.2015.06.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>B-Lymphocytes--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cell Transformation, Viral--immunology<br/>Cells, Cultured<br/>Epitopes, T-Lymphocyte--immunology<br/>Epstein-Barr Virus Infections--therapy<br/>Epstein-Barr Virus Nuclear Antigens--immunology<br/>Granzymes--metabolism<br/>Herpesvirus 4, Human--immunology<br/>Humans<br/>Interferon-gamma--immunology<br/>Perforin--biosynthesis<br/>Trans-Activators--immunology<br/>Viral Matrix Proteins--immunology